International Journal of Medical and Pharmaceutical Research
2026, Volume-7, Issue 2 : 3733-3736
Research Article
Heart Rate Variability in Young Adults with and without Family History of Hypertension: A Cross-Sectional Study
 ,
 ,
Received
April 4, 2026
Accepted
April 15, 2026
Published
April 29, 2026
Abstract

Introduction: Hypertension (HTN) is a major modifiable risk factor for cardiovascular disease and a leading cause of morbidity and mortality worldwide. Alterations in heart rate variability (HRV) have been associated with significant changes in cardiovascular outcomes, making HRV a clinically relevant marker in hypertensive individuals.

Objective: To evaluate and compare heart rate variability parameters in young adults with and without a family history of hypertension.

Materials and Methods: A cross-sectional study was conducted at Gandhi Medical College, Secunderabad, including 80 participants. Among them, 40 subjects had a family history of hypertension and 40 subjects had no such history. HRV was analyzed using time domain indices (NN interval, mean RR interval, SDNN, RMSSD) and frequency domain indices (total power, low frequency [LF], high frequency [HF], and LF/HF ratio).

Results: Frequency domain analysis showed an increase in LF (nu) values in subjects with a family history of hypertension, indicating increased sympathetic activity. A significant reduction in HF (nu) values (p = 0.04) was observed, suggesting decreased parasympathetic activity. RMSSD was also significantly reduced (p = 0.04), indicating reduced vagal tone.

Conclusion: Normotensive individuals with a family history of hypertension exhibit early autonomic imbalance characterized by increased sympathetic activity and reduced parasympathetic activity. HRV analysis may serve as a useful tool for early identification of individuals at risk of developing hypertension

Keywords
INTRODUCTION

Hypertension is one of the most prevalent non-communicable diseases globally and a major contributor to cardiovascular morbidity and mortality. It is estimated that over one billion individuals worldwide are affected, with a disproportionately higher burden in low- and middle-income countries such as India¹,². In India, the prevalence of hypertension is approximately 25–30% in urban populations and 10–15% in rural populations, with an increasing trend due to urbanization and lifestyle changes².

 

Family history is a well-established non-modifiable risk factor for hypertension, reflecting genetic predisposition and shared environmental influences. Offspring of hypertensive parents are at increased risk of developing hypertension compared to those without such a history³. These individuals may exhibit early physiological changes even before clinical onset.

 

The autonomic nervous system (ANS) plays a critical role in cardiovascular regulation. Dysregulation of ANS, characterized by increased sympathetic activity and reduced parasympathetic activity, has been implicated in the development of essential hypertension¹¹.

                                                                                                                                                                             

Heart rate variability (HRV) is a non-invasive and reliable tool used to assess autonomic function by measuring variations in the RR intervals between successive heartbeats¹⁰. Reduced HRV has been associated with increased cardiovascular morbidity, including hypertension, myocardial infarction, and heart failure¹².

 

HRV can be analyzed using time domain and frequency domain parameters. Standardized methods for HRV analysis have been established and are widely used in clinical and research settings⁹.

 

Recent studies have demonstrated that individuals with a family history of hypertension exhibit altered HRV parameters even in the normotensive state, suggesting early autonomic dysfunction⁴–⁸. These findings indicate that autonomic imbalance may precede the development of overt hypertension.

Therefore, the present study was undertaken to evaluate HRV parameters in young adults with and without a family history of hypertension.

 

MATERIALS AND METHODS:

Study Design and Setting

This cross-sectional observational study was conducted in the Department of Physiology at Gandhi Medical College, Secunderabad.

 

Study Population

A total of 80 healthy young adults aged between 18 and 25 years were included in the study.

 

Participants were divided into two groups:

  • Group A (Study Group): 40 individuals with a positive family history of hypertension (either parent diagnosed with hypertension)
  • Group B (Control Group): 40 individuals without any family history of hypertension

 

Inclusion Criteria

  • Healthy individuals aged 18–25 years
  • Both males and females
  • Willing to participate and provide informed consent

 

Exclusion Criteria

  • Known cases of hypertension, diabetes mellitus, or cardiovascular disease
  • History of smoking, alcohol consumption, or substance abuse
  • Individuals on medications affecting autonomic function
  • Acute illness or chronic systemic disease

 

Ethical Considerations: The study was conducted after obtaining approval from the Institutional Ethics Committee. Written informed consent was obtained from all participants prior to enrollment.

 

Study Procedure:

Participants were instructed to Avoid caffeine, heavy meals, and strenuous exercise for at least 12 hours prior to the test Report in a relaxed state

All recordings were performed in a quiet, temperature-controlled room with subjects in the supine position after adequate rest (10–15 minutes).

 

HRV Recording

Electrocardiographic (ECG) recordings were obtained under resting conditions in a quiet environment. HRV analysis was performed using standardized guidelines as recommended by the Task Force of the European Society of Cardiology⁹.

 

Parameters Studied

Time Domain Parameters

  • Mean RR Interval (ms): Average time between successive heartbeats
  • SDNN (ms): Standard deviation of all NN intervals, representing overall HRV
  • RMSSD (ms): Root mean square of successive differences, reflecting parasympathetic activity

 

Frequency Domain Parameters

  • Low Frequency (LF, nu): Reflects both sympathetic and parasympathetic activity but predominantly sympathetic when expressed in normalized units
  • High Frequency (HF, nu): Reflects parasympathetic (vagal) activity
  • LF/HF Ratio: Indicator of sympathovagal balance

These parameters reflect autonomic balance, with HF representing parasympathetic activity and LF reflecting both sympathetic and parasympathetic influences¹⁰.

 

Statistical Analysis

Statistical analysis was performed using SPSS 20.0. Data were expressed as mean ± SD and analyzed using Student’s unpaired t-test. A p-value < 0.05 was considered statistically significant.

 

RESULTS:

A total of 80 participants were included in the study, comprising 40 subjects with a family history of hypertension (study group) and 40 subjects without a family history (control group). Heart rate variability (HRV) parameters were analyzed using both time domain and frequency domain methods to assess autonomic function.

There was no statistically significant difference in age, height, weight, or body mass index (BMI) between subjects with and without a family history of hypertension (p > 0.05). (Table 1)

 

Table 1: Anthropometric parameters in subjects with and without family history of hypertension

 

Subjects with family history of hypertension

Subjects without family history of hypertension

 

 

P

 

value

MEAN

SD

MEAN

SD

Age

(years)

19.25

0.78

19.60

0.93

0.07

Height

(cm)

1.69

0.08

1.69

0.09

0.48

Weight

(kg)

62.96

10.47

65.03

10.86

0.38

BMI

22.11

3.12

22.46

2.82

0.59

 

There was no statistically significant difference in mean heart rate, mean RR interval, or SDNN between the two groups. However, RMSSD was significantly reduced in subjects with a family history of hypertension (p = 0.04), indicating decreased parasympathetic (vagal) activity in these individuals. (Table 2)

 

Table 2: Time Domain Parameters in Subjects With and Without Family History of Hypertension

Parameter

Family History

(Mean ± SD)

No Family History

(Mean ± SD)

p-value

Mean HR (beats/min)

87.78 ± 9.91

86.84 ± 11.52

0.70

Mean RR (ms)

699.17 ± 74.81

700.36 ± 93.27

0.95

SDNN (ms)

61.63 ± 25.56

58.94 ± 26.51

0.65

RMSSD (ms)

39.10 ± 14.30

45.59 ± 14.10

0.04*

SDSD (ms)

40.52 ± 16.35

44.64 ± 16.35

0.26

 

In the frequency domain analysis, LF values were higher in subjects with a family history of hypertension compared to controls, although this difference was not statistically significant. HF values were significantly reduced (p = 0.04), indicating reduced parasympathetic activity. The LF/HF ratio was increased in the study group, but this difference was not statistically significant. These findings suggest a trend toward sympathetic predominance and reduced vagal modulation in subjects with a family history of hypertension. (Table 3)

 

Table 3: Frequency Domain Parameters in Subjects With and Without Family History of Hypertension

Parameter

Family History

(Mean ± SD)

No Family History

(Mean ± SD)

p-value

LF (nu)

53.56 ± 17.73

48.50 ± 18.12

0.21

HF (nu)

42.60 ± 14.71

49.93 ± 17.84

0.04*

LF/HF Ratio

1.53 ± 1.02

1.33 ± 1.28

0.43

 

 

 

DISCUSSION:

The present study demonstrates early autonomic imbalance in normotensive individuals with a family history of hypertension. The findings of increased LF and decreased HF suggest a shift toward sympathetic dominance and reduced parasympathetic activity.

 

The LF component, particularly when expressed in normalized units, is considered an indicator of sympathetic activity, while HF is a direct measure of vagal tone¹⁰. The observed reduction in HF in the study group indicates decreased parasympathetic activity, which plays a protective role in cardiovascular regulation.

The reduction in RMSSD further supports decreased vagal modulation. RMSSD is a sensitive marker of short-term HRV and parasympathetic activity¹⁰. Reduced vagal tone has been associated with increased cardiovascular risk and progression of hypertension¹².

 

These findings are consistent with previous studies that have reported altered HRV parameters in individuals with a family history of hypertension⁵,⁸. Increased sympathetic activity and reduced parasympathetic activity may represent early pathophysiological changes preceding the onset of hypertension.

 

Although the LF/HF ratio was increased in the study group, it was not statistically significant. The LF/HF ratio has traditionally been used as an indicator of sympathovagal balance; however, its interpretation remains controversial and should be used cautiously⁷.

 

The underlying mechanisms may involve genetic predisposition, altered baroreceptor sensitivity, and early vascular changes that influence autonomic regulation¹¹. Increased sympathetic activity may lead to vasoconstriction and increased cardiac workload, ultimately contributing to the development of hypertension.

Thus, HRV analysis serves as a valuable, non-invasive tool for detecting early autonomic dysfunction. Early identification of at-risk individuals may allow implementation of preventive strategies such as lifestyle modification and regular monitoring.

 

CONCLUSION:

The present study demonstrates that normotensive young adults with a family history of hypertension exhibit early autonomic dysfunction, evidenced by reduced RMSSD and HF components indicating decreased parasympathetic activity, along with a trend toward sympathetic predominance. These findings suggest that autonomic imbalance may precede the clinical onset of hypertension, placing such individuals at a higher risk of developing the condition. Heart rate variability analysis, being a simple and non-invasive tool, may be useful for early detection and preventive management in high-risk individuals.

 

REFERENCES:

  1. World Health Organization. Hypertension. Geneva: WHO; 2023.
  2. Anchala R, Kannuri NK, Pant H, et al. Hypertension in India: a systematic review. J Hypertens. 2014;32(6):1170–1177.
  3. Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/AHA hypertension guideline. Hypertension. 2018;71:e13–e115.
  4. He B, Ji D, Zhang B. Hypertension and HRV correlation. Blood Press. 2024;33(1).
  5. Michael J, Chandran A, Mathew S, et al. HRV and BP control. Int J Med Public Health. 2024;14(4):241–244.
  6. Nirwal AS, Nagar S, Singh J. HRV in hypertensive individuals. J Life Sci Biotechnol Pharma Res. 2023;13(6):613–618.
  7. Yugar-Toledo JC, et al. HRV in hypertensive syndromes. Diagnostics. 2023;13:785.
  8. Kapadia NK, Thaker RB, Mehta JJ, Shah AR. HRV in hypertension. Natl J Physiol Pharm Pharmacol. 2023;13(10):2183–2186.
  9. Task Force of the European Society of Cardiology. HRV standards. Circulation. 1996;93:1043–1065.
  10. Shaffer F, Ginsberg JP. HRV metrics overview. Front Public Health. 2017;5:258.
  11. Grassi G, Mark A, Esler M. Sympathetic overactivity in hypertension. Circ Res. 2015;116:976–990.
  12. Thayer JF, Yamamoto SS, Brosschot JF. HRV and cardiovascular risk. Int J Cardiol. 2010;141:122–131.
Recommended Articles
Original Article Open Access
Assessment of Amniotic Fluid Index by Ultrasonography and Its Association with Maternal and Fetal Outcomes: A Prospective Observational Study from A Tertiary Care Center in Maharashtra
2026, Volume-7, Issue 2 : 3712-3717
DOI: 10.5281/zenodo.19878335
Research Article Open Access
Comparison Of Intrathecal Ropivacaine 0.5% Vs Levobupivacaine 0.5% In Infraumbilical Surgeries
2026, Volume-7, Issue 2 : 3737-3741
Original Article Open Access
ROLE OF DOPPLER ULTRASONOGRAPHY IN PREDICTING ADVERSE FETOMATERNAL OUTCOMES IN HIGH-RISK PREGNANCIES: A PROSPECTIVE OBSERVATIONAL STUDY
2026, Volume-7, Issue 2 : 3705-3711
DOI: 10.5281/zenodo.19877986
Research Article Open Access
Effect of High Protein versus Normo Protein Normo Caloric Feeding in Nutritionally High Risk Critically Ill Patients: A Randomized Controlled Trial
2026, Volume-7, Issue 2 : 3693-3698
International Journal of Medical and Pharmaceutical Research journal thumbnail
Volume-7, Issue 2
Citations
7 Views
11 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
Creative Commons Attribution License Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
facebook twitter linkedin mendeley research-gate
© Copyright | International Journal of Medical and Pharmaceutical Research | All Rights Reserved